Overview
At GeneThera Innovations, we are on a mission to revolutionize healthcare by developing innovative gene therapies targeting rare genetic disorders. Our proprietary platform harnesses cutting-edge CRISPR technology, enabling precise editing of genetic material to correct mutations responsible for debilitating diseases. Having successfully completed our initial proof-of-concept studies, we are at a pivotal stage where we require additional funding to build our capabilities and bring our therapies to a global audience. Since our inception in late 2024, we have made significant strides, including securing intellectual property rights, entering into collaborative research agreements with renowned academic institutions, and assembling a talented team of experts in genetics, biochemistry, and regulatory compliance. Our pre-clinical trials have shown promising results, demonstrating the potential efficacy of our approach, and we anticipate transitioning into clinical phases within the next year. To take our venture to the next level, we are seeking an investment of $760,000. These funds will primarily be allocated towards expanding our laboratory facilities, enhancing our research and deve…
Use of funds
The requested $760,000 will be primarily used for:
- Expanding lab facilities and equipment: $250,000
- Staffing additional researchers and regulatory experts: $200,000
- Clinical trial preparation and execution: $200,000
- Marketing and business development: $110,000
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.